|
year | Title | Num |
2020 | Novel Coronavirus (COVID-19): A New Emerging Pandemic Threat | 1 |
2020 | Management of critically ill patients with covid-19: What we learned and what we do | 2 |
2020 | Clinical manifestation, diagnosis, prevention and control of SARS-CoV-2 (COVID-19) during the outbreak period | 3 |
2020 | (Study of combining virtual screening and antiviral treatments of the SarsCoV-2 (Covid-19 | 4 |
2020 | SARS, MERS AND COVID-19, the story continues | 5 |
2020 | COVID-19: Is it the black death of the 21st century? | 6 |
2020 | Dexmedetomidine: An All sedation-In–one drug in critically ill patients with COVID-19 | 7 |
2020 | Early application of prone position for management of Covid-19 patients | 8 |
2020 | Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial | 9 |
2020 | Is Coronavirus Disease 2019 (COVID-19) Associated with Renal Involvement? A Review of Century Infection | 10 |
2020 | COVID-19 and Organ Transplantation? | 11 |
2020 | Management of Female and Functional Urology Patients During the COVID Pandemic | 12 |
2020 | Drug therapy in hospitalized patients with very severe symptoms following COVID-19 | 13 |
2020 | Renal patient guide during covid-19 | 14 |
2020 | A brief review of interplay between vitamin D and angiotensin-converting enzyme 2: Implications for a potential treatment forCOVID-19 | 15 |
2020 | COVID-19 outcomes in patients with systemic autoimmune diseases treated with immunomodulatory drugs | 16 |
2020 | Foodomics and COVID-19 | 17 |
2020 | Adherence to medication in patients with rheumatic diseases during COVID-19 pandemic | 18 |
2020 | Hemoperfusion as a Potential Treatment for Critically Ill COVID-19 Patients with Cytokine Storm | 19 |
2021 | The Role of Respiratory System Surface Area and Ventilation Volume in Severity and Mortality of COVID 19 Infection | 20 |
2021 | Clinical Manifestations of Neuro-COVID Syndrome | 21 |
2021 | Covid19-9 Infection Induced Hydrocephaly: A Case Report and Review the Article | 22 |
2020 | Prevalence of COVID-19 in patients with rheumatoid arthritis (RA) already treated with hydroxychloroquine (HCQ) compared with HCQ-naive patients with RA: A multicentre crosssectional study | 23 |
2021 | Potential role of glycoprotein 340 in milder SARS-CoV-2 infection in children | 24 |
2021 | Factors associated with COVID-19 and its outcome in patients with rheumatoid arthritis | 25 |
2021 | Micronutrient therapy and effective immune response: a promising approach for management of COVID-19 | 26 |
2020 | COVID-19 outcomes in patients with systemic autoimmune diseases treated with immunomodulatory drugs | 27 |
2020 | Adherence to medication in patients with rheumatic diseases during COVID-19 pandemic | 28 |
2020 | A brief review of interplay between vitamin D and angiotensin‐converting enzyme 2: Implications for a potential treatment for COVID‐19 | 29 |
2020 | Treatments for COVID-19: Emerging drugs against the coronavirus | 30 |
2020 | Clinical manifestation, diagnosis prevention and control of SARS-CoV-2 (COVID-19) during the outbreak period | 31 |
2021 | An Umbrella Review of Clinical Efficacy and Adverse Cardiac Events Associated with Hydroxychloroquine or Chloroquine with or Without Azithromycin in Patients with COVID-19 | 32 |
2020 | A Review on the Neurological Manifestations of COVID-19 Infection: a Mechanistic View | 33 |
2021 | Dose the Global Outbreak of COVID-19 or Other Viral Diseases Threaten the Stem Cell Reservoir Inside the Body? | 34 |
2021 | An overview of Betacoronaviruses-associated severe respiratory syndromes,focusing on sex-type-specific immune responses | 35 |
2021 | CovidCTNet: an open-source deep learning approach to diagnose covid-19 using small cohort of CT images | 36 |
2021 | U.S.-Imposed Economic Sanctions on Iran in the COVID-19 Crisis From the Human Rights Perspective | 37 |
2020 | Iran, Information Technology Governance, 2019 Novel Coronavirus Response | 38 |
2020 | Information Technology Efforts Against COVID-19: A Review of Open Source Projects | 39 |
2020 | Winning the COVID-19 War: McKinsey & Company's Proposed Plan for Action at the Local Level | 40 |
2020 | Emerging and Re‐emerging Diseases: Policies and Strategies for Future | 41 |
2020 | The Main Issues and Challenges Older Adults Face in the SARSCoV-2 Pandemic: A Scoping Review of Literature | 42 |
2020 | Effectiveness of the non-pharmaceutical public health interventions against COVID-19; a protocol of a systematic review and realist review | 43 |
2021 | Applications of virtual and augmented reality in infectious disease epidemics with a focus on the COVID-19 outbreak | 44 |
2020 | COVID-19 & an NGO and university developed interactive portal: a perspective from Iran | 45 |
2021 | E-health roadmap for COVID-19 vaccine coverage in Iran | 46 |
2021 | Information and information resources in COVID-19: Awareness, control, and prevention | 47 |
2020 | The need for an integrated portal: Effective approach for infodemic management in Covid19 | 48 |
2021 | Application of Information Technology Models, Approaches and Tools in Covid-19 Management: Rapid Review | 49 |
2020 | Toward Controlling Coronavirus Disease 2019 (COVID-19) Pandemic by Integrated Registry Systems | 50 |
2020 | Electronic screening through community engagement: A national strategic plan to find COVID-19 patients and reduce clinical intervention delays | 51 |
2021 | راهبردهای کشورهای شرق آسیا در مواجهه مؤثر با کووید- 91 : درس آموخته هایی برای ایران | 52 |
2020 | Battle with COVID-19 in Iran: What lessons can be learned from the implementation of reaction strategies so far? | 53 |